The ₹20 Crore Profit Gap That Broke Trust
GSPL reported ₹120 crore in Q2 net profit, but the actual delivered result was ₹99.5 crore—a 17% miss. Revenue growth is real, but earnings credibility needs urgent repair.
₹120 Cr
management stated on call
₹99.5 Cr
actual filed result
₹20.5 Cr
17% shortfall · actual YoY -16%, not +2%
Revenue is real; profit credibility is not
The Q2 result shows revenue of ₹289.6 crore, up 8% year-on-year—that holds up. EBITDA of ₹169 crore at 58.4% margin is likewise supported. But when net profit hits—₹99.5 crore—the story breaks. Management reported ₹120 crore PAT on the call. The delivered result shows ₹99.5 crore. That is a ₹20.5 crore gap (17%), unexplained on the call. Worse: management claimed "PAT of ₹120 crores, up 2% YoY." The actual delivered PAT is down 16% year-on-year, not up 2%. The credibility damage is material.
The gap likely reflects overlapping items: consolidated subsidiary drag (GIGL and GITL are loss-making JVs), non-operating interest income (~₹20 crore annually from deposits, excluded from operating PAT), and possible tax or fair-value adjustments. Management did not reconcile the gap in real time—a critical omission. That silence, more than the gap itself, is the red flag.
Q2 standalone revenue of ₹290 Cr, up 8% YoY
₹289.6 Cr delivered—claim accurate within rounding
Supported
EBITDA of ₹169 Cr at 58.4% margin
289.6 × 58.4% = 169.04 Cr—validated
Supported
PAT of ₹120 Cr, up 2% YoY vs 118 Cr prior year
Delivered ₹99.5 Cr; YoY decline ~16%, not +2%. ₹20.5 Cr shortfall vs reported
Overstated (17% miss)
H1 PAT of ₹258 Cr vs 255 Cr prior year, +1.2% growth
Q2 miss of ₹20.5 Cr suggests H1 figure is also inflated; reconciliation incomplete
Overstated (pending detail)
What changed on this call
Volume reporting shift: Management disclosed a methodological change from physical molecule volumes to contractual volumes (take-or-pay basis). This explains the reported jump to 40 MMSCMD contractually. GIGL volumes grew 20%, revenue only +13–18%—a mismatch analysts pressed hard on. Management's answer: contractual-vs.-physical mix and high-pressure network benefits (50% capex bonus) are non-linear. Revenue impact was not recalculated retroactively; future quarters report on the new basis.
Capex locked in and EPC awarded: Prior quarters saw vague forward planning. This call formalized it: ₹3,500 crore capex over 2–2.5 years (FY27–FY28/FY29), board-approved, with the flagship Anjar-Palanpur 700 km project now EPC-awarded at ₹1,800 crore. Execution risk is real (large infrastructure projects slip), but the decision is made. Management: "almost every project is now in execution stage."
Profit headwinds disclosed: CFO acknowledged that as the ₹2,500 crore cash deploys into capex over FY27–FY28, non-operating interest income (~₹20 crore annually) will decline to near-zero. This is a ₹15–20 crore annual PAT headwind starting FY28. Capex should generate incremental EBITDA by FY29, but there is a 2-year timing gap where consolidated PAT will be pressured.
The growth story: ₹3,500 crore capex, 2028 tariff inflection
The bull thesis: capacity expansion in a structural growth market. Current: 36.5 MMSCMD on GTL (Gujarat). Target by Mar 2028: 45.5 MMSCMD—24.7% increase. Network expands 2,900 km → 3,600 km. India's gas mix is rising 6% → 15% by 2030; GSPL is positioned for this tailwind.
Tariff regime: Fixed until 2028 revision (expected ~2028). No margin expansion for 3–4 years. Cost inflation (steel, labour) will erode margins unless offset by volume growth. Management expects 12% post-tax ROCE on capex—solid but not aggressive. The 2028 tariff revision is the catalyst: rate increase would reset PAT upward; delay extends margin pressure.
Subsidiary ramp: GIGL (1,439 km Gail JV) and GITL (365 km Andhra-Telangana) are loss-making. GIGL volumes +20%, revenue only +13–18% (unfavourable tariff mix). GITL constrained by KG Basin sourcing. Both to hit breakeven in "couple of years" as new demand (LNG, industries, Canada/Argentina gas) online. Until then, consolidated PAT lags parent PAT by ₹5–10 crore annually.
Structural gas demand growth; India energy mix 6% → 15% by 2030
Quasi-monopoly in Gujarat; ₹3,500 Cr capex board-approved and execution-ready
Debt-free balance sheet; ₹7,150 Cr net worth; cash generative
Tariff fixed until 2028; margin expansion blocked by cost inflation for 3–4 years
Reported profit missed delivered by 17% (₹120 Cr vs ₹99.5 Cr); credibility gap
Interest income cliff as capex deploys; ₹15–20 Cr PAT headwind FY28 onwards
GIGL & GITL loss-making; 2–3 year breakeven path; consolidated PAT drag
12% capex ROE assumption not backed by project-level transparency; tariff risk post-2028
Profit delivery credibility gap (₹20.5 Cr PAT miss; claimed +2% growth vs actual -16%)
HighUnexplained 17% gap destroys earnings quality. If this repeats, valuation multiple compresses. Credibility must reset in Q3 or stock re-rates downward.
Tariff fixed until 2028 (no margin expansion; cost inflation erodes returns)
HighNo rate hike for 3–4 years. Cost inflation (steel, labour) will erode margins unless passed to customers (unlikely pre-2028). Capex ROI will be lower than 12% assumed if costs spike.
Interest income cliff as ₹2,500 Cr cash deploys; ₹15–20 Cr PAT headwind FY28 onwards
HighNon-operating income currently ~₹20 Cr annually. Deposits fall to near-zero as capex deploys. Structural PAT headwind FY28–FY29 even if capex on track.
Subsidiary drag (GIGL & GITL loss-making; 2–3 year breakeven horizon)
MediumConsolidated PAT lags parent-standalone by ~₹5–10 Cr annually. GITL sourcing constrained by KG Basin. Timeline to breakeven is vague.
Regulatory risk (PNGRB appeals pending; 2028 tariff timing uncertain)
MediumPending appeals on volume claims and denied tariff adjustments. Adverse outcomes prospective-only (no retroactive recovery). Tariff revision timing post-2028 is uncertain.
Capex execution risk (₹3,500 Cr over 2–2.5 years; land, environmental delays common)
MediumLarge pipeline projects often slip (land acquisition, environmental clearances, contractor execution). If Anjar-Palanpur misses Mar 2028 or costs overrun, revenue accretion delayed and ROI declines.
How the street is positioned
The stock is signalling doubt. Current price: ₹106.65 (Nov 6, 2026). 52-week range: ₹104–₹144.4. Stock is down 26% from ATH of ₹144.4, near the 52-week low, up just 2.55% from the low. RSI 29.2—deeply oversold (<30 is the threshold). Volume trend is decreasing; the selloff is a slow grind down, not capitulation panic.
FII positioning: On Oct 9, 2026, Norges Bank (Government Pension Fund Global—sovereign wealth) sold ~20 lakh shares @ ₹106.23. Significant exit by a foreign institutional holder, timing post-Q2 result and call, signals the earnings miss and credibility gap triggered a de-rating. Foreign institutional money is exiting or defensive on India infrastructure valuations.
Valuation context: Stock has given back almost all post-IPO gains (IPO ₹105–₹120 in 2024; ATH ₹144). Current ₹106 is a near-retest of IPO level. For a company with board-approved ₹3,500 crore capex, debt-free balance sheet, and structural tailwinds, the de-rating is steep. However, the profit miss and capex timing gap (revenue accretion FY29 onwards, while interest income vanishes FY27–FY28) create a 2-year earnings trough. Market is pricing that trough and risk that capex ROI assumptions miss.
Street's implicit call: Oversold RSI and volume decline suggest capitulation is incomplete. If earnings credibility is restored in Q3 and capex execution confirmed, stock could re-rate 15–20% upward. If Q3 profit misses again or capex gets delayed, further downside. Hold-rated investors wait for clarity; new buyers are absent pending credibility reset.
1 · Q3 earnings reconciliation and organic profit run-rate
The ₹20.5 crore Q2 PAT gap must be explained in the next result. Provide a bridge from reported to delivered, breaking out subsidiary impact, non-op items, and tax adjustments. Track Q3 PAT ex-interest income and ex-subsidiaries for true operational run-rate.
2 · Anjar-Palanpur capex execution pace (Mar 2028 target)
The ₹1,800 crore EPC contract is the flagship capex project. Quarterly updates on land acquisition, construction progress, and on-time delivery are essential. Any delays to March 2028 or cost overruns will push revenue accretion to FY29 and compress capex ROI.
3 · PNGRB appellate decisions and 2028 tariff timing
Pending appeals on volume claims and tariff adjustments need clarity. PNGRB should indicate whether 2028 tariff revision will be on schedule or delayed. Tariff timing uncertainty extends margin pressure window. Favorable appellate outcome could justify a re-rating.
GSPL's story is a multi-year infrastructure play with real structural tailwinds and disciplined capex execution. But profit delivery is broken, and the next 2–3 years will be a grind as capex depletes cash and interest income vanishes. The honest read: this is a hold, not a buy. Reset credibility with Q3 earnings, confirm capex execution on Anjar-Palanpur, and the stock re-rates. Until then, wait for clarity. The number to track from here is organic adjusted PAT (ex-interest income, ex-subsidiaries)—that is where real operational margin sits and where management's 12% capex ROE assumption will be tested.
Informational and educational content only. Not investment advice.